Skip to content

Bernd G. Disse

Boehringer Ingelheim (Germany)

1 paper in the Anchorcite directory, published in 2014, cited 4,771 times in total.

Research topics

Frequent co-authors

Papers

  1. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary FibrosisNew England Journal of Medicine · 2014 · 4,771 citations

    BACKGROUND: Nintedanib (formerly known as BIBF 1120) is an intracellular inhibitor that targets multiple tyrosine kinases. A phase 2 trial suggested that treatment with 150 mg of nintedanib twice daily reduced lung-function decline and acute exacerbations in patients with idiopathic…

Metadata from OpenAlex (CC0).